Physician profile
John F Harb
NPI 1811967334
$21,115.95
in general payments reported to CMS, 2019-2025
45 companies · $1,837 in 2025
The $1,837 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,907 · 2020: $1,211 · 2021: $3,179 · 2022: $2,350 · 2023: $2,499 · 2024: $6,134 · 2025: $1,837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,000 · Food and Beverage: $3,937 · Travel and Lodging: $1,478 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,000.00 |
| Food and Beverage | $3,936.95 |
| Travel and Lodging | $1,477.57 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,419.81 | 2021-2025 | Interstim |
| Neotract INC. | $2,728.32 | 2019-2020 | |
| Teleflex LLC | $2,264.53 | 2021-2025 | Urolift, Barrigel |
| Coloplast Corp | $1,732.08 | 2019-2025 | Porges Coloplast |
| Astellas Pharma US INC | $904.03 | 2019-2025 | Xtandi, Myrbetriq |
| Medtronic USA, INC. | $771.65 | 2019-2020 | |
| Pfizer INC. | $691.91 | 2019-2025 | |
| Janssen Biotech, INC. | $465.39 | 2019-2025 | Erleada, Akeega |
| Laborie Medical Technologies Corp. | $399.99 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Dendreon Pharmaceuticals LLC | $361.30 | 2019 | |
| Endo Pharmaceuticals INC. | $255.01 | 2019-2024 | Xiaflex |
| Axonics, INC. | $162.19 | 2020-2022 | |
| Blue Earth Diagnostics | $161.17 | 2019-2021 | |
| Myovant Sciences INC. | $142.72 | 2021-2022 | |
| Boston Scientific Corporation | $142.49 | 2020-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, Greenlight Xps |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Harb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.